In contrast, epithelial cells of the tumor only expressed the luminal type CK18 as the original tumor

In contrast, epithelial cells of the tumor only expressed the luminal type CK18 as the original tumor

In contrast, epithelial cells of the tumor only expressed the luminal type CK18 as the original tumor. or enriched in mammospheres, and not CD24+or CD29+cells, were responsible for the sphere generationin vitro. Moreover, cells from your tumor spheres showed an increased tumor-generating ability in respect to the epithelial tumor cells. Sca-1+sorted cells or clonal mammospheres derived from a Sca-1+cell showed a superimposable tumor-initiating ability. The data of the present study indicate that a Sca-1+populace derived from mammary BALB-neuT tumors is responsible for sphere generation in culture and for initiating tumorsin vivo. == Introduction == Growing evidences support the hypothesis that this tumorigenic process is usually sustained by a small populace of cells, named tumor-initiating cells or tumor stem cells [1,2]. Tumor-initiating cells are characterized by their ability to form new serially transplantable tumors in mice and to display stem/progenitor cell properties such as competence for self-renewal and capacity to reestablish tumor heterogeneity [3,4]. Tumor stem cells have been identified in several human solid tumors and isolated by the selection for specific different markers [511]. In human breast carcinoma, the tumor-initiating cells have been recognized by Al Hajj et al. [12] as a rare populace of CD44+/CD24-/low/epithelial-specific antigen+cells. Furthermore, tumor-initiating cells were also isolated for the ability to grow as nonadherent spheres. This house was first explained for neuronal progenitors [13] and then extended to progenitors of the mammary gland [14], to human breast cell lines [15], and to human and murine breast carcinomas [1618]. In this condition of culture, tumor-initiating cells can be expanded and managed in an undifferentiated state [16]. In mouse mammary glands, transgenic activation of different oncogenic pathways generates tumors with particular histopathologic features, resembling the human specific types of breast carcinomas [19]. In particular, CD19 the transgenic activation ofWntinduces tumors of epithelial and myoepithelial origin, suggesting that tumors may arise from multilineage progenitor cells. In contrast, the activation of Her-2/neuoncogene (neu) generates tumors with cells more strictly committed to the luminal fate [20,21], suggesting the involvement of luminalrestricted progenitors [22]. The presence and characteristics of stem/tumor-initiating cells in the model of the mouse mammary neoplasia driven SB 203580 hydrochloride by the activated transforming form of ratneuoncogene (BALB-neuT mice) are still unknown. This model is usually characterized by the overexpression of the activated ratneuoncogene under the control of the mouse mammary tumor computer virus promoter (MMTV) [23]. The transgene encodes a 185-kDa transmembrane tyrosine kinase receptor, which is usually prevalently expressed in mammary glands of these mice. At 3 weeks of age, female BALB-neuT mice start a process of quick development of tumors including all SB 203580 hydrochloride the mammary glands. Tumor progression in BALB-neuT mice is usually closely comparable to that of human carcinoma, progressing from atypical hyperplasia to invasive tumor with short latency [24].Moreover, in human breast carcinoma, it has been recently described that Her-2 overexpression increased the number of stem/progenitor cells [25]. It is therefore of interest to isolate the stem cell populace in a model of Her-2 activation and to identify a marker for their selection. In the present study, we aimed to evaluate whether there is a SB 203580 hydrochloride populace of stem/tumor-initiating cells in the BALB-neuT tumor model. For this purpose, we generated tumor spheres from main spontaneous tumors. Tumor spheres cultures were characterized for the self-renewal, differentiative ability and for their tumorigenic potential. In addition, we evaluated the chemoresistance of the tumor sphere to doxorubicin compared with that of parental tumor cells. Finally, we investigated whether tumor sphere-generating cells expressed selective stem cell markers that allow the identification of this populace. In particular, we evaluated whether cells expressing Sca-1 were enriched in tumor spheres and were responsible for the sphere generationin vitroand for initiating tumorsin vivo. == Materials and Methods == == Isolation andIn VitroExpansion of Tumor Sphere-Forming Cells from Mammary Tumor Specimens == Main mammary tumor specimens were obtained from spontaneous carcinomas developed in BALB-neuT female mice transporting the activated form of ratneuoncogene [23,24]. The histologic assessment showed a human-like lobular carcinoma of alveolar type. Tumor specimens (each time 36 spontaneous tumors from your same mouse;n= 15) were finely minced with scissors and then digested by incubation for 30 minutes at.